258 related articles for article (PubMed ID: 20388717)
1. In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification.
Blomster HA; Imanishi SY; Siimes J; Kastu J; Morrice NA; Eriksson JE; Sistonen L
J Biol Chem; 2010 Jun; 285(25):19324-9. PubMed ID: 20388717
[TBL] [Abstract][Full Text] [Related]
2. Site-specific identification and quantitation of endogenous SUMO modifications under native conditions.
Lumpkin RJ; Gu H; Zhu Y; Leonard M; Ahmad AS; Clauser KR; Meyer JG; Bennett EJ; Komives EA
Nat Commun; 2017 Oct; 8(1):1171. PubMed ID: 29079793
[TBL] [Abstract][Full Text] [Related]
3. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
4. Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation.
Filosa G; Barabino SM; Bachi A
Neuromolecular Med; 2013 Dec; 15(4):661-76. PubMed ID: 23979992
[TBL] [Abstract][Full Text] [Related]
5. Positively charged amino acids flanking a sumoylation consensus tetramer on the 110kDa tri-snRNP component SART1 enhance sumoylation efficiency.
Schimmel J; Balog CI; Deelder AM; Drijfhout JW; Hensbergen PJ; Vertegaal AC
J Proteomics; 2010 Jun; 73(8):1523-34. PubMed ID: 20346425
[TBL] [Abstract][Full Text] [Related]
6. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif.
Matic I; Schimmel J; Hendriks IA; van Santen MA; van de Rijke F; van Dam H; Gnad F; Mann M; Vertegaal AC
Mol Cell; 2010 Aug; 39(4):641-52. PubMed ID: 20797634
[TBL] [Abstract][Full Text] [Related]
7. Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites.
Blomster HA; Hietakangas V; Wu J; Kouvonen P; Hautaniemi S; Sistonen L
Mol Cell Proteomics; 2009 Jun; 8(6):1382-90. PubMed ID: 19240082
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
9. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
[TBL] [Abstract][Full Text] [Related]
10. "ChopNSpice," a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides.
Hsiao HH; Meulmeester E; Frank BT; Melchior F; Urlaub H
Mol Cell Proteomics; 2009 Dec; 8(12):2664-75. PubMed ID: 19721078
[TBL] [Abstract][Full Text] [Related]
11. SUMO assay with peptide arrays on solid support: insights into SUMO target sites.
Schwamborn K; Knipscheer P; van Dijk E; van Dijk WJ; Sixma TK; Meloen RH; Langedijk JP
J Biochem; 2008 Jul; 144(1):39-49. PubMed ID: 18344540
[TBL] [Abstract][Full Text] [Related]
12. Identification of protein SUMOylation sites by mass spectrometry using combined microwave-assisted aspartic acid cleavage and tryptic digestion.
Osula O; Swatkoski S; Cotter RJ
J Mass Spectrom; 2012 May; 47(5):644-54. PubMed ID: 22576878
[TBL] [Abstract][Full Text] [Related]
13. A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation.
Albuquerque CP; Yeung E; Ma S; Fu T; Corbett KD; Zhou H
PLoS One; 2015; 10(12):e0143810. PubMed ID: 26633173
[TBL] [Abstract][Full Text] [Related]
14. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy.
Matic I; van Hagen M; Schimmel J; Macek B; Ogg SC; Tatham MH; Hay RT; Lamond AI; Mann M; Vertegaal ACO
Mol Cell Proteomics; 2008 Jan; 7(1):132-44. PubMed ID: 17938407
[TBL] [Abstract][Full Text] [Related]
15. SUMO: getting it on.
Anckar J; Sistonen L
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
[TBL] [Abstract][Full Text] [Related]
16. Identification of SUMO E3 ligase-specific substrates using the HuProt human proteome microarray.
Cox E; Uzoma I; Guzzo C; Jeong JS; Matunis M; Blackshaw S; Zhu H
Methods Mol Biol; 2015; 1295():455-63. PubMed ID: 25820740
[TBL] [Abstract][Full Text] [Related]
17. System-wide identification of wild-type SUMO-2 conjugation sites.
Hendriks IA; D'Souza RC; Chang JG; Mann M; Vertegaal AC
Nat Commun; 2015 Jun; 6():7289. PubMed ID: 26073453
[TBL] [Abstract][Full Text] [Related]
18. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
19. A high-yield double-purification proteomics strategy for the identification of SUMO sites.
Hendriks IA; Vertegaal AC
Nat Protoc; 2016 Sep; 11(9):1630-49. PubMed ID: 27560170
[TBL] [Abstract][Full Text] [Related]
20. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
Tang Z; Hecker CM; Scheschonka A; Betz H
FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
